CBS News @CBSNews
U.S. health officials approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. https://t.co/aUP9uq1Dns — PolitiTweet.org